List of SBIR/STTR awards granted to Cancer Targeted Technology
A SBIR Phase II contract was awarded to Cancer Targeted Technology in September, 2021 for $1,000,002.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Cancer Targeted Technology in July, 2019 for $1,375,908.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Cancer Targeted Technology in September, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Cancer Targeted Technology in March, 2015 for $2,000,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Cancer Targeted Technology for $1,145,108.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cancer Targeted Technology for $307,641.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Cancer Targeted Technology for $2,000,000.0 USD from the U.S. Department of Health & Human Services.
